Vanguard Capital Management
OLMA icon

Vanguard Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Vanguard Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.8M Buy
3,341,217
+257,700
+8% +$3.45M ﹤0.01% 2048
2026
Q1 		$46M Buy
+3,083,517
New +$68.6M ﹤0.01% 1894

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Capital Management's OLMA Position: Q2 2026 in Review

Vanguard Capital Management increased its Olema Pharmaceuticals (OLMA) stake by 8.4% in Q2 2026, buying an estimated $3.45M and bringing the position to 3,341,217 shares worth $41.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2048.

Vanguard Capital Management first reported a position in OLMA in Q1 2026 and has held it in 2 quarters since. The position peaked at $46M in Q1 2026. 183 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Vanguard Capital Management held 3,341,217 shares of Olema Pharmaceuticals worth $41.8M as of Q2 2026.
  • Vanguard Capital Management bought 257,700 Olema Pharmaceuticals shares in Q2 2026, an estimated $3.45M.
  • Olema Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2048 holding.
  • Vanguard Capital Management first reported a position in Olema Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Olema Pharmaceuticals position peaked at $46M in Q1 2026.
  • 183 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.